Generic Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers the Global Generic Drug Market Size, Trends, and Share and is Segmented by Route of Administration (Oral, Topical, Injectable, and Other Routes of Administration), Application (Cardiovascular Products, Anti-Infective Drugs, Central Nervous System Drugs, Anti-Cancer Drugs, Respiratory Products, and Other Applications), Distribution Channel (Hospitals/Clinics, Retail Pharmacies, and Other Distribution Channels), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Report Offers the Value (USD) for the Above Segments.

Generic Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Generic Drugs Industry Overview

The global generic drugs market is highly competitive, with many players dominating the market. The market players are adopting strategies such as rising R&D investment, mergers, acquisitions, and product innovations to sustain the increasing market rivalry. The key market players include Mylan NV, Eli Lilly and Company, GlaxoSmithKline PLC, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Novartis AG, and Sanofi.

Generic Drugs Market Leaders

  1. Sanofi

  2. Pfizer

  3. Teva Pharmaceutical Industries Limited

  4. Abbott Laboratories

  5. Sun Pharmaceutical Industries Ltd.

  6. *Disclaimer: Major Players sorted in no particular order
 Generic Drugs Market Concentration